8D6K | pdb_00008d6k

Sco GlgEI-V279S in complex with cyclohexyl carbasugar


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.73 Å
  • R-Value Free: 
    0.259 (Depositor), 0.254 (DCC) 
  • R-Value Work: 
    0.191 (Depositor), 0.190 (DCC) 
  • R-Value Observed: 
    0.193 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8D6K

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Synthesis of C 7 /C 8 -cyclitols and C 7 N-aminocyclitols from maltose and X-ray crystal structure of Streptomyces coelicolor GlgEI V279S in a complex with an amylostatin GXG-like derivative.

Thanvi, R.Jayasinghe, T.D.Kapil, S.Obadawo, B.S.Ronning, D.R.Sucheck, S.J.

(2022) Front Chem 10: 950433-950433

  • DOI: https://doi.org/10.3389/fchem.2022.950433
  • Primary Citation Related Structures: 
    8D6K

  • PubMed Abstract: 

    C 7 /C 8 -cyclitols and C 7 N-aminocyclitols find applications in the pharmaceutical sector as α-glucosidase inhibitors and in the agricultural sector as fungicides and insecticides. In this study, we identified C 7 /C 8 -cyclitols and C 7 N-aminocyclitols as potential inhibitors of Streptomyces coelicolor ( Sco ) GlgEI-V279S based on the docking scores. The protein and the ligand (targets 11 , 12 , and 13 ) were prepared, the states were generated at pH 7.0 ± 2.0, and the ligands were docked into the active sites of the receptor via Glide™. The synthetic route to these targets was similar to our previously reported route used to obtain 4-⍺-glucoside of valienamine ( AGV ), except the protecting group for target 12 was a p -bromobenzyl (PBB) ether to preserve the alkene upon deprotection. While compounds 11 - 13 did not inhibit Sco GlgEI-V279S at the concentrations evaluated, an X-ray crystal structure of the Sco GlgE1-V279S/ 13 complex was solved to a resolution of 2.73 Å. This structure allowed assessment differences and commonality with our previously reported inhibitors and was useful for identifying enzyme-compound interactions that may be important for future inhibitor development. The Asp 394 nucleophile formed a bidentate hydrogen bond interaction with the exocyclic oxygen atoms (C(3)-OH and C(7)-OH) similar to the observed interactions with the Sco GlgEI-V279S in a complex with AGV (PDB:7MGY). In addition, the data suggest replacing the cyclohexyl group with more isosteric and hydrogen bond-donating groups to increase binding interactions in the + 1 binding site.


  • Organizational Affiliation
    • Department of Chemistry and Biochemistry, The University of Toledo, Toledo, OH, United States.

Macromolecule Content 

  • Total Structure Weight: 153.73 kDa 
  • Atom Count: 10,662 
  • Modeled Residue Count: 1,298 
  • Deposited Residue Count: 1,366 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase 1A [auth B],
B [auth A]
683Streptomyces coelicolor A3(2)Mutation(s): 1 
Gene Names: glgE1pep1pep1Apep1ISCO5443SC6A11.19c
EC: 2.4.99.16
UniProt
Find proteins for Q9L1K2 (Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145))
Explore Q9L1K2 
Go to UniProtKB:  Q9L1K2
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9L1K2
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.73 Å
  • R-Value Free:  0.259 (Depositor), 0.254 (DCC) 
  • R-Value Work:  0.191 (Depositor), 0.190 (DCC) 
  • R-Value Observed: 0.193 (Depositor) 
Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 112.438α = 90
b = 112.438β = 90
c = 310.411γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
HKL-2000data reduction
SCALAdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2022-10-19
    Type: Initial release
  • Version 1.1: 2023-10-18
    Changes: Data collection, Refinement description